A beloved company that has been part of the fabric of the US and has served hundreds of millions of customers around the ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Eli Lilly and Co.

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Nearly 4 in 10 American adults are estimated to have a liver condition that can lead to serious complications and even death.

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

The recent surge has been due to the tremendous growth Lilly has achieved due to its highly popular GLP-1 drugs, including ...

As Forbes has tracked for years, there are plenty of perfectly legal ways for senior government officials to become quite ...